title: Rate control in atrial fibrillation: many questions still unanswered.
authors.affiliation: From Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, The Netherlands. i.c.van.gelder@umcg.nl.
authors.forename: Isabelle C
authors.initials: IC
authors.lastname: Van Gelder
authors.affiliation: From Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, The Netherlands.
authors.forename: Anne H
authors.initials: AH
authors.lastname: Hobbelt
authors.affiliation: From Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, The Netherlands.
authors.forename: Bart A
authors.initials: BA
authors.lastname: Mulder
authors.affiliation: From Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, The Netherlands.
authors.forename: Michiel
authors.initials: M
authors.lastname: Rienstra
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004077:Digoxin / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D004077:Digoxin
keywords: Editorials; digoxin; heart rate; mortality; β-blocker